Company
EQL Pharma AB
Headquarters: Lund, Sweden
Employees: 11
CEO: Mr. Christer Fahraeus B.Sc. Maths, h.c., MSc Bio Eng, Ph.D.
Market Cap
€87.0 Million
EUR as of Jan. 1, 2024
US$96.1 Million
EQL Pharma AB Categories
Sweden Healthcare Drug Manufacturers—Specialty & GenericSweden Healthcare Sweden Drug Manufacturers—Specialty & Generic
Top Competitors by Market Capitalization
Industry: Drug Manufacturers—Specialty & Generic
| Company | Market Cap (USD) |
|---|---|
| Zoetis Inc. | $89.09 B |
| MERCK Kommanditgesellschaft auf Aktien | $67.64 B |
| Takeda Pharmaceutical Company Limited | $47.71 B |
| Haleon plc | $38.90 B |
| PPD, Inc. | $16.58 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Detailed Description
EQL Pharma AB (publ) engages in the development, marketing, and sale of specialty and generic medicines to pharmacies and hospitals in Europe. The company was incorporated in 2006 and is based in Lund, Sweden.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Stocks & Indices
EQL Pharma AB has the following listings and related stock indices.
Stock: FSX: 7JK wb_incandescent